Phosphorous (24 Hour Urine) Test – Accurate Kidney Function & Metabolic Health Assessment with Spectrophotometry
110,00 د.إSample Type : 24 Hour Urine
Methodology : Spectrophotometry
TAT : 1 Day
Showing 17–22 of 22 results
-
-
Porphyrins (RBCs) Test – Accurate Whole Blood Analysis for Heme Synthesis Disorders, Porphyrias, and Lead Poisoning Detection
320,00 د.إSample Type : Whole Blood
Methodology : Spectrophotometry
TAT : 10 Days -
ROS1 FISH Test – Accurate Genetic Testing for Targeted Cancer Therapy
3.750,00 د.إThe **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine.
-
Valproic Acid (Depakin Level) Serum Test – Accurate Enzyme-Immunoassay for Epilepsy, Bipolar Disorder, and Migraine Management
280,00 د.إThe Valproic Acid (Depakin Level) Serum Test is a precise enzyme-immunoassay designed to monitor valproic acid levels in patients undergoing treatment for epilepsy, bipolar disorder, or migraine.
Sample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 3 Days
-
Vancomycin Serum Test – Enzyme-Immunoassay for MRSA, C. difficile, and Gram-Positive Infections | 10-Day TAT
440,00 د.إSample Type : Serum
Methodology : Enzyme-immunoassay
TAT : 10 Days -
Whole Exome Sequencing
5.375,00 د.إWhole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research.
